Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema
Clinical trial NCT02633852 · COMPLETED
Trial details
- NCT number
- NCT02633852
- Sponsor
- Hadassah Medical Organization
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-24
- Primary completion
- 2018-08-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.